- Home
- RELL vs APLT Comparison
RELL vs APLT Comparison
Compare RELL & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RELL
- APLT
- Stock Information
- Founded
- RELL 1947
- APLT 2016
- Country
- RELL United States
- APLT United States
- Employees
- RELL N/A
- APLT N/A
- Industry
- RELL Electronic Components
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- RELL Technology
- APLT Health Care
- Exchange
- RELL Nasdaq
- APLT Nasdaq
- Market Cap
- RELL 149.6M
- APLT 178.6M
- IPO Year
- RELL N/A
- APLT 2019
- Fundamental
- Price
- RELL $10.05
- APLT $0.25
- Analyst Decision
- RELL
- APLT Buy
- Analyst Count
- RELL 0
- APLT 5
- Target Price
- RELL N/A
- APLT $4.13
- AVG Volume (30 Days)
- RELL 57.4K
- APLT 25.0M
- Earning Date
- RELL 01-06-2026
- APLT 11-13-2025
- Dividend Yield
- RELL 2.35%
- APLT N/A
- EPS Growth
- RELL N/A
- APLT N/A
- EPS
- RELL 0.01
- APLT N/A
- Revenue
- RELL $209,791,000.00
- APLT $1,000,000.00
- Revenue This Year
- RELL $4.72
- APLT N/A
- Revenue Next Year
- RELL $14.93
- APLT $5,935.35
- P/E Ratio
- RELL $835.11
- APLT N/A
- Revenue Growth
- RELL 6.17
- APLT N/A
- 52 Week Low
- RELL $7.57
- APLT $0.22
- 52 Week High
- RELL $15.51
- APLT $10.48
- Technical
- Relative Strength Index (RSI)
- RELL 48.63
- APLT 27.49
- Support Level
- RELL $9.37
- APLT $0.25
- Resistance Level
- RELL $10.28
- APLT $0.40
- Average True Range (ATR)
- RELL 0.46
- APLT 0.11
- MACD
- RELL -0.06
- APLT -0.05
- Stochastic Oscillator
- RELL 58.84
- APLT 4.17
About RELL Richardson Electronics Ltd.
Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. The company's segment includes Power and Microwave Technologies, Green Energy Solutions, Canvys, and Healthcare. The company generates the majority of its revenue from the Power and Microwave Technologies segment, which includes the power grid and microwave tube business and RF, Wireless and Power technologies.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.